{"title":"肺移植术后原发性移植物功能障碍的发生率及其相关危险因素:系统回顾和荟萃分析。","authors":"Jing Pan, Jiejuan Zhang, Xiali Lu","doi":"10.1007/s00595-025-03129-4","DOIUrl":null,"url":null,"abstract":"<p><p>This meta-analysis evaluates the prevalence of primary graft dysfunction (PGD) and its risk factors after lung transplantation (LT). We searched databases (PubMed, EMBASE, Cochrane Library, Web of Science) up until May, 2024. STATA 16 was used for data analysis. Random or fixed effects models were used to summarize the prevalence of PGD and associated risk factors according to statistical tests for heterogeneity. Risk of bias was assessed with the Newcastle-Ottawa Scale. A total of 61 studies with 59,865 patients were included. The pooled prevalence of grade 2 and grade 3 PGD was 27% (95% CI 0.19, 0.34) and 18% (0.16, 0.21), respectively. Donor-related risk factors included older age (OR = 1.04; 95% CI 1.00, 1.58), female gender (OR = 1.67; 95% CI 1.13, 2.48), and smoking history (OR = 1.84; 1.47, 2.30). Recipient factors were female gender (OR = 1.51; 95% CI 1.32, 1.74), higher BMI (OR = 1.22; 95% CI 1.11, 1.33), idiopathic pulmonary fibrosis (OR = 2.08; 95% CI 1.64, 2.63), and pulmonary hypertension (OR = 2.19; 95% CI 1.50, 3.21). Operative risks included higher reperfusion FiO<sub>2</sub> (OR = 1.13; 95% CI 1.01, 1.23), prolonged ischemic time (OR = 1.03; 95% CI 1.01, 1.05), and cardiopulmonary bypass use (OR = 2.38; 95% CI 1.79, 3.16). This study highlights the donor, recipient, and operative factors contributing to PGD risk, and emphasizes the need for targeted strategies in high-risk populations and further mechanistic research.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Incidence of primary graft dysfunction and its associated risk factors after lung transplantation: a systematic review and meta-analysis.\",\"authors\":\"Jing Pan, Jiejuan Zhang, Xiali Lu\",\"doi\":\"10.1007/s00595-025-03129-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This meta-analysis evaluates the prevalence of primary graft dysfunction (PGD) and its risk factors after lung transplantation (LT). We searched databases (PubMed, EMBASE, Cochrane Library, Web of Science) up until May, 2024. STATA 16 was used for data analysis. Random or fixed effects models were used to summarize the prevalence of PGD and associated risk factors according to statistical tests for heterogeneity. Risk of bias was assessed with the Newcastle-Ottawa Scale. A total of 61 studies with 59,865 patients were included. The pooled prevalence of grade 2 and grade 3 PGD was 27% (95% CI 0.19, 0.34) and 18% (0.16, 0.21), respectively. Donor-related risk factors included older age (OR = 1.04; 95% CI 1.00, 1.58), female gender (OR = 1.67; 95% CI 1.13, 2.48), and smoking history (OR = 1.84; 1.47, 2.30). Recipient factors were female gender (OR = 1.51; 95% CI 1.32, 1.74), higher BMI (OR = 1.22; 95% CI 1.11, 1.33), idiopathic pulmonary fibrosis (OR = 2.08; 95% CI 1.64, 2.63), and pulmonary hypertension (OR = 2.19; 95% CI 1.50, 3.21). Operative risks included higher reperfusion FiO<sub>2</sub> (OR = 1.13; 95% CI 1.01, 1.23), prolonged ischemic time (OR = 1.03; 95% CI 1.01, 1.05), and cardiopulmonary bypass use (OR = 2.38; 95% CI 1.79, 3.16). This study highlights the donor, recipient, and operative factors contributing to PGD risk, and emphasizes the need for targeted strategies in high-risk populations and further mechanistic research.</p>\",\"PeriodicalId\":22163,\"journal\":{\"name\":\"Surgery Today\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgery Today\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00595-025-03129-4\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery Today","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00595-025-03129-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
摘要
本荟萃分析评估肺移植(LT)后原发性移植物功能障碍(PGD)的患病率及其危险因素。我们检索了截止到2024年5月的数据库(PubMed, EMBASE, Cochrane Library, Web of Science)。使用STATA 16进行数据分析。采用随机或固定效应模型,根据异质性的统计检验,总结PGD患病率及相关危险因素。偏倚风险采用纽卡斯尔-渥太华量表进行评估。共纳入61项研究,59,865例患者。2级和3级PGD的总患病率分别为27% (95% CI 0.19, 0.34)和18%(0.16,0.21)。供体相关的危险因素包括年龄较大(OR = 1.04; 95% CI 1.00, 1.58)、女性(OR = 1.67; 95% CI 1.13, 2.48)和吸烟史(OR = 1.84; 1.47, 2.30)。受体因素为女性(OR = 1.51; 95% CI 1.32, 1.74)、较高的BMI (OR = 1.22; 95% CI 1.11, 1.33)、特发性肺纤维化(OR = 2.08; 95% CI 1.64, 2.63)和肺动脉高压(OR = 2.19; 95% CI 1.50, 3.21)。手术风险包括再灌注FiO2升高(OR = 1.13; 95% CI 1.01, 1.23)、缺血时间延长(OR = 1.03; 95% CI 1.01, 1.05)和体外循环使用(OR = 2.38; 95% CI 1.79, 3.16)。本研究强调了供体、受体和手术因素对PGD风险的影响,并强调了在高危人群中有针对性的策略和进一步的机制研究的必要性。
Incidence of primary graft dysfunction and its associated risk factors after lung transplantation: a systematic review and meta-analysis.
This meta-analysis evaluates the prevalence of primary graft dysfunction (PGD) and its risk factors after lung transplantation (LT). We searched databases (PubMed, EMBASE, Cochrane Library, Web of Science) up until May, 2024. STATA 16 was used for data analysis. Random or fixed effects models were used to summarize the prevalence of PGD and associated risk factors according to statistical tests for heterogeneity. Risk of bias was assessed with the Newcastle-Ottawa Scale. A total of 61 studies with 59,865 patients were included. The pooled prevalence of grade 2 and grade 3 PGD was 27% (95% CI 0.19, 0.34) and 18% (0.16, 0.21), respectively. Donor-related risk factors included older age (OR = 1.04; 95% CI 1.00, 1.58), female gender (OR = 1.67; 95% CI 1.13, 2.48), and smoking history (OR = 1.84; 1.47, 2.30). Recipient factors were female gender (OR = 1.51; 95% CI 1.32, 1.74), higher BMI (OR = 1.22; 95% CI 1.11, 1.33), idiopathic pulmonary fibrosis (OR = 2.08; 95% CI 1.64, 2.63), and pulmonary hypertension (OR = 2.19; 95% CI 1.50, 3.21). Operative risks included higher reperfusion FiO2 (OR = 1.13; 95% CI 1.01, 1.23), prolonged ischemic time (OR = 1.03; 95% CI 1.01, 1.05), and cardiopulmonary bypass use (OR = 2.38; 95% CI 1.79, 3.16). This study highlights the donor, recipient, and operative factors contributing to PGD risk, and emphasizes the need for targeted strategies in high-risk populations and further mechanistic research.
期刊介绍:
Surgery Today is the official journal of the Japan Surgical Society. The main purpose of the journal is to provide a place for the publication of high-quality papers documenting recent advances and new developments in all fields of surgery, both clinical and experimental. The journal welcomes original papers, review articles, and short communications, as well as short technical reports("How to do it").
The "How to do it" section will includes short articles on methods or techniques recommended for practical surgery. Papers submitted to the journal are reviewed by an international editorial board. Field of interest: All fields of surgery.